Randomized Controlled Trial of the Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

被引:0
|
作者
Gogenur, Mikail [1 ]
Gogenur, Ismail [1 ]
机构
[1] Zealand Univ Hosp, Ctr Surg Sci, Dept Surg, Roskilde, Denmark
关键词
OPEN SURGERY; ANESTHESIA; REDUCTION; MORTALITY;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:E105 / E106
页数:2
相关论文
共 50 条
  • [21] Quality of adjuvant chemotherapy in stage III colon cancer
    Krzyzanowska, Monika Karolina
    Gao, Julia
    He, Helena
    Hertz, Sherrie
    Kukreti, Vishal
    Kaizer, Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [22] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
    Grothey, A.
    Sobrero, A. F.
    Shields, A. F.
    Yoshino, T.
    Paul, J.
    Taieb, J.
    Souglakos, J.
    Shi, Q.
    Kerr, R.
    Labianca, R.
    Meyerhardt, J. A.
    Vernerey, D.
    Yamanaka, T.
    Boukovinas, I.
    Meyers, J. P.
    Renfro, L. A.
    Niedzwiecki, D.
    Watanabe, T.
    Torri, V.
    Saunders, M.
    Sargent, D. J.
    Andre, T.
    Iveson, T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1177 - 1188
  • [23] Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
    Megumi Ishiguro
    Hidetaka Mochizuki
    Naohiro Tomita
    Yasuhiro Shimada
    Keiichi Takahashi
    Kenjiro Kotake
    Masahiko Watanabe
    Yukihide Kanemitsu
    Hideki Ueno
    Toshiaki Ishikawa
    Hiroyuki Uetake
    Shigeyuki Matsui
    Satoshi Teramukai
    Kenichi Sugihara
    BMC Cancer, 12
  • [24] Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
    Ishiguro, Megumi
    Mochizuki, Hidetaka
    Tomita, Naohiro
    Shimada, Yasuhiro
    Takahashi, Keiichi
    Kotake, Kenjiro
    Watanabe, Masahiko
    Kanemitsu, Yukihide
    Ueno, Hideki
    Ishikawa, Toshiaki
    Uetake, Hiroyuki
    Matsui, Shigeyuki
    Teramukai, Satoshi
    Sugihara, Kenichi
    BMC CANCER, 2012, 12
  • [25] ADJUVANT MFOLFOX6 IN THE TREATMENT OF ELDERLY COLON CANCER PATIENTS
    Godinho Bexiga, J.
    Carneiro, F.
    Marques, D. S.
    Sousa, N.
    Raimundo, A.
    Machado, M.
    Ferreira, P.
    Faustino, C.
    Fragoso, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 221 - 221
  • [26] Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial
    Yoshimura, Kenichi
    Uehara, Keisuke
    Tojima, Yuichiro
    Kawai, Satoru
    Mokuno, Yasuji
    Maeda, Atsuyuki
    Kyokane, Takanori
    Kobayashi, Satoshi
    Yoshioka, Yuichiro
    Nagino, Masato
    TRIALS, 2013, 14
  • [27] Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial
    Kenichi Yoshimura
    Keisuke Uehara
    Yuichiro Tojima
    Satoru Kawai
    Yasuji Mokuno
    Atsuyuki Maeda
    Takanori Kyokane
    Satoshi Kobayashi
    Yuichiro Yoshioka
    Masato Nagino
    Trials, 14
  • [28] Perioperative chemotherapy with mFOLFOX6 or CAPOX for patients with locally advanced colon cancer (OPTICAL): A multicenter, randomized, phase 3 trial.
    Hu, Huabin
    Huang, Meijin
    Li, Yunfeng
    Wang, Ziqiang
    Wang, Xiaozhong
    Liu, Ping
    Zhang, Ruyi
    Zhang, Hao
    Huang, Zhongcheng
    Pei, Haiping
    Zeng, Yongming
    Lai, Jiajun
    Chen, Wenbin
    Chen, Jiansi
    Ding, Zhijie
    Wei, Hongbo
    Xu, Qingwen
    Chen, Jigui
    Wang, Jianping
    Deng, Yanhong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy
    Bouvier, Anne-Marie
    Minicozzi, Pamela
    Grosclaude, Pascale
    Bouvier, Veronique
    Faivre, Jean
    Sant, Milena
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (08) : 687 - 691
  • [30] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON OVERALL SURVIVAL OF STAGE II AND III COLON CANCER
    Sekkate, Sakina
    Abahssain, Halima
    Serji, Badr
    Boutayeb, Saber
    Mrabti, Hind
    Errihani, Hassan
    ANNALS OF ONCOLOGY, 2011, 22 : v88 - v88